Iovance Biotherapeutics Stock Market Value
| IOVA Stock | USD 2.61 0.01 0.38% |
| Symbol | Iovance |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iovance Biotherapeutics. Market participants price Iovance higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Iovance Biotherapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.19) | Revenue Per Share | Quarterly Revenue Growth 0.152 | Return On Assets | Return On Equity |
Understanding Iovance Biotherapeutics requires distinguishing between market price and book value, where the latter reflects Iovance's accounting equity. The concept of intrinsic value - what Iovance Biotherapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Iovance Biotherapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Iovance Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Iovance Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Iovance Biotherapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Iovance Biotherapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Iovance Biotherapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Iovance Biotherapeutics.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Iovance Biotherapeutics on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Iovance Biotherapeutics or generate 0.0% return on investment in Iovance Biotherapeutics over 90 days. Iovance Biotherapeutics is related to or competes with Ginkgo Bioworks, MBX Biosciences, Erasca, Replimune, MeiraGTx Holdings, MoonLake Immunotherapeuti, and Vir Biotechnology. Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer ... More
Iovance Biotherapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Iovance Biotherapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Iovance Biotherapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.29 | |||
| Information Ratio | 0.1016 | |||
| Maximum Drawdown | 37.34 | |||
| Value At Risk | (7.58) | |||
| Potential Upside | 11.81 |
Iovance Biotherapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Iovance Biotherapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Iovance Biotherapeutics' standard deviation. In reality, there are many statistical measures that can use Iovance Biotherapeutics historical prices to predict the future Iovance Biotherapeutics' volatility.| Risk Adjusted Performance | 0.1033 | |||
| Jensen Alpha | 0.6634 | |||
| Total Risk Alpha | 0.0371 | |||
| Sortino Ratio | 0.1425 | |||
| Treynor Ratio | 1.68 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Iovance Biotherapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Iovance Biotherapeutics February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1033 | |||
| Market Risk Adjusted Performance | 1.69 | |||
| Mean Deviation | 4.28 | |||
| Semi Deviation | 4.02 | |||
| Downside Deviation | 4.29 | |||
| Coefficient Of Variation | 847.82 | |||
| Standard Deviation | 6.02 | |||
| Variance | 36.26 | |||
| Information Ratio | 0.1016 | |||
| Jensen Alpha | 0.6634 | |||
| Total Risk Alpha | 0.0371 | |||
| Sortino Ratio | 0.1425 | |||
| Treynor Ratio | 1.68 | |||
| Maximum Drawdown | 37.34 | |||
| Value At Risk | (7.58) | |||
| Potential Upside | 11.81 | |||
| Downside Variance | 18.44 | |||
| Semi Variance | 16.18 | |||
| Expected Short fall | (5.41) | |||
| Skewness | 1.58 | |||
| Kurtosis | 5.13 |
Iovance Biotherapeutics Backtested Returns
At this point, Iovance Biotherapeutics is risky. Iovance Biotherapeutics holds Efficiency (Sharpe) Ratio of 0.0317, which attests that the entity had a 0.0317 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Iovance Biotherapeutics, which you can use to evaluate the volatility of the firm. Please check out Iovance Biotherapeutics' Risk Adjusted Performance of 0.1033, market risk adjusted performance of 1.69, and Downside Deviation of 4.29 to validate if the risk estimate we provide is consistent with the expected return of 0.16%. Iovance Biotherapeutics has a performance score of 2 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.42, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Iovance Biotherapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Iovance Biotherapeutics is expected to be smaller as well. Iovance Biotherapeutics right now retains a risk of 4.93%. Please check out Iovance Biotherapeutics expected short fall, and the relationship between the value at risk and daily balance of power , to decide if Iovance Biotherapeutics will be following its current trending patterns.
Auto-correlation | -0.08 |
Very weak reverse predictability
Iovance Biotherapeutics has very weak reverse predictability. Overlapping area represents the amount of predictability between Iovance Biotherapeutics time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Iovance Biotherapeutics price movement. The serial correlation of -0.08 indicates that barely 8.0% of current Iovance Biotherapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.08 | |
| Spearman Rank Test | -0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Iovance Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Iovance Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Iovance Biotherapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Iovance Biotherapeutics Stock:Check out Iovance Biotherapeutics Correlation, Iovance Biotherapeutics Volatility and Iovance Biotherapeutics Performance module to complement your research on Iovance Biotherapeutics. For information on how to trade Iovance Stock refer to our How to Trade Iovance Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Iovance Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.